Thompson DA, Weigel RJ. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem. 1998;252(1):169–77.
Article CAS PubMed Google Scholar
van Camp G, Coucke P, Balemans W, van Velzen D, van de Bilt C, van Laer L, Smith RJ, Fukushima K, Padberg GW, Frants RR, et al. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet. 1995;4(11):2159–63.
Van Laer L, Huizing EH, Verstreken M, van Zuijlen D, Wauters JG, Bossuyt PJ, Van de Heyning P, McGuirt WT, Smith RJ, Willems PJ, et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet. 1998;20(2):194–7.
Huizing EH, van Bolhuis AH, Odenthal DW. Studies on progressive hereditary perceptive deafness in a family of 335 members. I. Genetical and general audiological results. Acta Otolaryngol. 1966;61(1):35–41.
Article CAS PubMed Google Scholar
Huizing EH, van Bolhuis AH, Odenthal DW. Studies on progressive hereditary perceptive deafness in a family of 335 members. II. Characteristic pattern of hearing deterioration. Acta Otolaryngol. 1966;61(1):161–7.
Article CAS PubMed Google Scholar
Mehl AL, Thomson V. Newborn hearing screening: the great omission. Pediatrics. 1998;101(1):E4.
Article CAS PubMed Google Scholar
Liu Y, Tan M, Cai L, Lv L, Chen Q, Chen W, Yang H, Xu Y. Genetic profiles of non-syndromic severe-profound hearing loss in Chinese Hans by whole-exome sequencing. Gene. 2022;819:146258.
Article CAS PubMed Google Scholar
Aboagye ET, Adadey SM, Wonkam-Tingang E, Amenga-Etego L, Awandare GA, Wonkam A. Global Distribution of Founder Variants Associated with non-syndromic hearing impairment. Genes (Basel). 2023;14(2):14.
Cheng J, Li T, Tan Q, Fu J, Zhang L, Yang L, Zhou B, Yang L, Fu S, Linehan AG, et al. Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree. J Cell Mol Med. 2024;28(1):e18004.
Article CAS PubMed Google Scholar
Op de Beeck K, Van Camp G, Thys S, Cools N, Callebaut I, Vrijens K, Van Nassauw L, Van Tendeloo VF, Timmermans JP, Van Laer L. The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein. Eur J Hum Genet. 2011;19(9):965–73.
Article CAS PubMed Google Scholar
De Schutter E, Croes L, Ibrahim J, Pauwels P, Op de Beeck K, Vandenabeele P, Van Camp G. GSDME and its role in cancer: from behind the scenes to the front of the stage. Int J Cancer. 2021;148(12):2872–83.
Kim MS, Chang X, Yamashita K, Nagpal JK, Baek JH, Wu G, Trink B, Ratovitski EA, Mori M, Sidransky D. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 2008;27(25):3624–34.
Article CAS PubMed Google Scholar
Zhang Z, Zhao S, Yang H, Chen Y, Feng H, An M, Chen B. Prognostic and immunological role of gasdermin E in Pan-cancer Analysis. Front Oncol. 2021;11:706266.
Article CAS PubMed PubMed Central Google Scholar
Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–20.
Article CAS PubMed PubMed Central Google Scholar
Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017;8:14128.
Article CAS PubMed PubMed Central Google Scholar
Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–5.
Article CAS PubMed Google Scholar
Kong Q, Zhang Z. Cancer-associated pyroptosis: a new license to kill tumor. Front Immunol. 2023;14:1082165.
Article CAS PubMed PubMed Central Google Scholar
Wang J, Sun Z, Xie J, Ji W, Cui Y, Ai Z, Liang G. Inflammasome and pyroptosis in autoimmune liver diseases. Front Immunol. 2023;14:1150879.
Article CAS PubMed PubMed Central Google Scholar
Privitera G, Rana N, Armuzzi A, Pizarro TT. The gasdermin protein family: emerging roles in gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol. 2023;20(6):366–87.
Article PubMed PubMed Central Google Scholar
Fu J, Song B, Du J, Liu S, He J, Xiao T, Zhou B, Li D, Liu X, He T, et al. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2. Mol Biol Rep. 2023;50(3):2269–81.
Article CAS PubMed Google Scholar
Liu S, Yang L, Fu J, Li T, Zhou B, Wang K, Wei C, Fu J. Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues. Front Immunol. 2023;14:1149986.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Dong X, Ding X, Liu G, Yang F, Song Q, Sun H, Chen G, Li S, Li Y, et al. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/beta-catenin signal pathway. J Transl Med. 2023;21(1):900.
Article CAS PubMed PubMed Central Google Scholar
Chen G, Zhang H, Sun H, Ding X, Liu G, Yang F, Feng G, Dong X, Zhu Y, Wang X, et al. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway. Apoptosis. 2023;28(9–10):1390–405.
Article CAS PubMed Google Scholar
Cunningham KG, Manson W, Spring FS, Hutchinson SA. Cordycepin, a metabolic product isolated from cultures of cordyceps militaris (Linn.) Link. Nature. 1950;166(4231):949.
Article CAS PubMed Google Scholar
Radhi M, Ashraf S, Lawrence S, Tranholm AA, Wellham PAD, Hafeez A, Khamis AS, Thomas R, McWilliams D, de Moor CH. A systematic review of the Biological effects of Cordycepin. Molecules. 2021;26(19):5886.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Guo ZJ, Zhou XW. Chinese cordyceps: Bioactive Components, Antitumor effects and underlying Mechanism-A review. Molecules. 2022;27(19):6576.
Article CAS PubMed PubMed Central Google Scholar
Tan L, Song X, Ren Y, Wang M, Guo C, Guo D, Gu Y, Li Y, Cao Z, Deng Y. Anti-inflammatory effects of cordycepin: a review. Phytother Res 2020.
Das G, Shin HS, Leyva-Gomez G, Prado-Audelo MLD, Cortes H, Singh YD, Panda MK, Mishra AP, Nigam M, Saklani S, et al. Cordyceps spp.: a review on its Immune-Stimulatory and other Biological potentials. Front Pharmacol. 2020;11:602364.
Article CAS PubMed Google Scholar
Wei C, Yao X, Jiang Z, Wang Y, Zhang D, Chen X, Fan X, Xie C, Cheng J, Fu J, et al. Cordycepin inhibits drug-resistance non-small cell Lung Cancer Progression by activating AMPK Signaling Pathway. Pharmacol Res. 2019;144:79–89.
Article CAS PubMed Google Scholar
Wei C, Khan MA, Du J, Cheng J, Tania M, Leung EL, Fu J. Cordycepin inhibits triple-negative breast Cancer Cell Migration and Invasion by regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1. Front Oncol. 2022;12:898583.
留言 (0)